loading…
Q5001 Hospice or home health care provided in patient's home/residence
BackQ5001Hospice or home health care provided in patient's home/residence→Q5002Hospice or home health care provided in assisted living facility→Q5003Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)→Q5004Hospice care provided in skilled nursing facility (snf)→Q5005Hospice care provided in inpatient hospital→Q5006Hospice care provided in inpatient hospice facility→Q5007Hospice care provided in long term care facility→Q5008Hospice care provided in inpatient psychiatric facility→Q5009Hospice or home health care provided in place not otherwise specified (nos)→Q5010Hospice home care provided in a hospice facility→Q5098Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg→Q5099Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg→Q5100Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg→Q5101Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram→Q5103Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg→Q5104Injection, infliximab-abda, biosimilar, (renflexis), 10 mg→Q5105Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units→Q5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units→Q5107Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg→Q5108Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg→Q5110Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram→Q5111Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg→Q5112Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg→Q5113Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg→Q5114Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg→Q5115Injection, rituximab-abbs, biosimilar, (truxima), 10 mg→Q5116Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg→Q5117Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg→Q5118Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg→Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg→Q5120Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg→Q5121Injection, infliximab-axxq, biosimilar, (avsola), 10 mg→Q5122Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg→Q5123Injection, rituximab-arrx, biosimilar, (riabni), 10 mg→Q5124Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg→Q5125Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram→Q5126Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg→Q5127Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg→Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg→Q5129Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg→Q5130Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg→Q5133Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg→Q5134Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg→Q5135Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg→Q5136Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg→Q5137Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg→Q5138Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg→Q5140Injection, adalimumab-fkjp, biosimilar, 1 mg→Q5141Injection, adalimumab-aaty, biosimilar, 1 mg→Q5142Injection, adalimumab-ryvk biosimilar, 1 mg→Q5143Injection, adalimumab-adbm, biosimilar, 1 mg→Q5144Injection, adalimumab-aacf (idacio), biosimilar, 1 mg→Q5145Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg→Q5146Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg→Q5147Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg→Q5148Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram→Q5149Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg→Q5150Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg→Q5151Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg→Q5152Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg→Q5153Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg→Q5154Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg→Q5155Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg→Q5156Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg→Q5157Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg→Q5158Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg→Q5159Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg→Q5160Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg→Q5161Injection, denosumab-kyqq (aukelso/bosaya), biosimilar, 1 mg→Q5162Injection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mg→Q5164Injection, ustekinumab-hmny (starjemza), biosimilar, 1 mg→Q5165Injection, denosumab-mobz (oziltus), biosimilar, 1 mg→Q5166Injection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mg→Q5167Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mg→Q5168Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg→Q5169Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg→Q5170Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mg→Q5171Injection, denosumab-mobz (boncresa), biosimilar, 1 mg→Q5172Injection, filgrastim-laha (filkri), biosimilar, 1 microgram→Q5173Injection, denosumab-adet (ponlimsi), biosimilar, 1 mg→
Procedure codeCODABLE
Q5001
Hospice or home health care provided in patient's home/residence
CODING INFORMATION
SEE ONLINE MANUAL 100-02.9.
- Part
- HCPCS Level II
- Q
- Temporary Codes
- Q5
- Q5001–Q5173
Source
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.